by Vora Corporate Finance | Dec 30, 2024 | Insights
The International Monetary Fund (IMF) upgraded India’s GDP projections by 20 basis points to 7 percent, from previous estimate of 6.8 percent in April, reflecting carryover from upward revisions to growth in 2023 and improved prospects for private consumption,...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Merger & Acquisitions
Transaction: Ahead of the merger, Aster will purchase a 5.0% stake in Quality Care from Blackstone and TPG in consideration of primary share issuance by Aster for a 3.6% stake. Post the initial share acquisition, Quality Care will be merged into Aster by way of a...
by Vora Corporate Finance | Dec 16, 2024 | Insights
The BSE Sensex closed at 79,803 up by 0.52% and the Nifty 50 closed at 24,131 down by 0.31% in November 2024, driven by concerns over stretched valuations, weak performance by Indian Inc in Q2 and persistent selloffs by foreign investors. From a sector perspective,...
by Vora Corporate Finance | Dec 16, 2024 | Insights
The Monetary Policy Committee (MPC) of the RBI, which met in Mumbai in December 2024, kept the Repo rate unchanged at 6.5% in a majority 4-2 decision. This is the eleventh consecutive monetary policy, over 22 months, which has left the Repo rate unchanged. The MPC has...
